Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Person › Details

Amber Fennell (Consilium Strategic Communications Ltd. (CSC))

Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder)

 

Organisation Organisation Consilium Strategic Communications Ltd. (CSC)
Products Product public relations / investor relations / marcom (services)
  Product 2 healthcare
     

Consilium Strategic Communications Ltd.. (7/25/13). "Press Release: Consilium Strategic Communications Company Launch. Europe’s Only Healthcare Specialist Financial PR and IR Firm Launched Today". London.

- Europe's only healthcare specialist financial PR and IR firm launched today


Consilium Strategic Communications (Consilium), Europe's only dedicated strategic communications advisor for the healthcare sector, has launched today as a spin-off from M:Communications. Consilium will provide strategic financial and corporate communications advice to international companies across the healthcare industry.

Consilium's well-established senior team of healthcare specialists has worked together over many years and draws upon decades of healthcare industry experience. The team will continue to work with public and private healthcare companies internationally across the pharma, biotech, medtech and healthcare services arenas. Consilium's extensive network provides unparalleled access to key industry stakeholders and influential commentators worldwide.

The Company, headquartered in the City of London, will be led by Mary-Jane Elliott together with fellow co-founder Amber Bielecka and Emma Thompson who will join the team in August to spearhead Asian operations from Singapore. Consilium's ability to offer its clients truly global advisory capabilities is strengthened by its trusted network of international affiliates.

Consilium will continue to provide a full rostrum of specialist communications services, encompassing financial communications, cross-border transactional support, reputation management and crisis communications, through to guidance on corporate and social responsibility strategies.

Consilium's clients already range from leaders in the healthcare services sector through to large multinational pharmas and innovative and exciting new technology companies. The Company also advises leading charities and government bodies.

Mary-Jane Elliott, Managing Partner of Consilium Strategic Communications, commented: "The spin-out and launch of Consilium Strategic Communications allows us to intensify our focus on our clients with our dedicated sector approach and to provide unmatched capabilities across all levels of the healthcare sector on a truly international scale. I am proud to be launching Europe's only healthcare focused financial PR and IR company and the team in London is delighted that Emma Thompson will spearhead our Asian operations, an increasingly important geography for our clients.

"Consilium proactively partners with clients to forge impactful and long-term communications strategies with a fresh-thinking, independent and global approach. The Company is wholly owned by its employees, creating an attractive new home for ambitious talent in the sector. Our unique focus enables us to offer our clients unparalleled access to key stakeholders on a global scale, making Consilium the only PR and IR advisor to offer such a unique and comprehensive healthcare communications proposition."

Mark L. Wilson, CEO of DF King Worldwide, M:Communications' parent company, added: "We wish the Consilium team good luck in their new venture and every success for the future."

Follow us: @consiliumcomm - https://twitter.com/consiliumcomm


About Consilium Strategic Communications

Consilium Strategic Communications is Europe and Asia's only dedicated independent healthcare financial public relations and investor relations firm. Consilium's highly-skilled team provides strategic, long-term advice to corporations, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects. http://www.consilium-comms.com

For more information please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Bielecka
Tel: +44(0)20-7920-2345 / +44-(0)20-7920-2352
Elliott@consilium-comms.com / Bielecka@consilium-comms.com
http://www.consilium-comms.com

   
Record changed: 2018-11-12

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px


More documents for Amber Fennell


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top